Latest filing published 10 Apr 2026 for 셀트리온제약, €15.7M. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 셀트리온 across 2 companies, led by 셀트리온제약 and 셀트리온. Between 1 April 2021 and 10 April 2026, the trades on record add up to 63 filings.
On the market, this insider has only ever bought: 11 purchases, €15.7M in total. The totals exclude 10 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show 2 purchases and no sales.
On 2 out of 10 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 10 April 2026 came the latest disclosure, an open-market purchase for €15.7M in 셀트리온제약. Between a trade and the moment it shows up on DART (FSS), the median delay is 6 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 63 declarations